The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy
Nadine Van Roy, Katleen De Preter, Jasmien Hoebeeck, Tom Van Maerken, Filip Pattyn, Pieter Mestdagh, Joƫlle Vermeulen, Jo Vandesompele, Frank Speleman
July 2009